-
Study Explores Holistic Effects Of Medical Cannabis Versus Opioids On Chronic Pain Management
Tuesday, November 21, 2023 - 5:35pm | 512Read More...A recent study, spearheaded by Professor Jussi Jylkkä and a team of researchers from Åbo Akademi University delved into the holistic effects of medical cannabis and opioids on chronic pain, providing valuable insights into their efficacy. The study, recently published in the...
-
Does Legal Access To CBD Reduce Opioid Prescription Rates? New Study Investigates
Friday, November 3, 2023 - 9:58am | 523Read More...Titled "CBD as a cure-all? The impacts of state-level legalization of prescription cannabidiol (CBD) on opioid prescriptions," delves into the effects of state-level legalization of CBD acceess on opioid prescribing rates. See Also: Fentanyl Fuels Ongoing US Drug Overdose Crisis: Over 109...
-
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal
Tuesday, May 17, 2022 - 12:08pm | 271Read More...Prospects of a global opioid deal getting done in 2022 suggest a “potential path to upside” for Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) stock, according to BofA Securities. The Teva Pharmaceutical Industries Analyst: Jason Gerberry upgraded the rating for Teva...
-
Opiant Pharma Advances OPNT003 PK Study With First Patient Dosing
Tuesday, February 9, 2021 - 12:30pm | 221Read More...Opiant Pharmaceuticals Inc (NASDAQ: OPNT) doses the first patient in a confirmatory pharmacokinetic (PK) study evaluating OPNT003 (nasal nalmefene) for opioid overdose treatment. Results from the study are anticipated in June 2021. The open-label, randomized, crossover study...
-
White House To Loosen Controls On Heroin Addiction Treatment
Wednesday, July 6, 2016 - 9:00am | 308Read More...The Wall Street Journal recently reported President Obama’s administration will loosen its strict controls on a medication called buprenorphine, which is used to treat addiction to heroin and other opioid-based drugs. The Department of Health and Human Services up until now only allowed...
